Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema - Reply

被引：10
|
作者：
Beck, TR
Baird, LG
机构：
[1] Dyax Corp, Business & Prod Dev, Cambridge, MA 02139 USA
[2] Dyax Corp, Dev, Cambridge, MA 02139 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2005.10.044
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [31] Oral plasma kallikrein inhibitor BCX7353 for treatment of hereditary angioedema
    Hwang, Jacqueline R.
    Hwang, Gloria
    Johri, Ansh
    Craig, Timothy
    IMMUNOTHERAPY, 2019, 11 (17) : 1439 - 1444
  • [32] Subcutaneous DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema: results from the integrated analysis of phase 3, double-blind, placebo-controlled studies
    Sheffer, A.
    Levy, R.
    Li, H.
    Horn, P.
    Pullman, W.
    ALLERGY, 2009, 64 : 13 - 14
  • [33] C1 Inhibitor Therapy and Hereditary Angioedema The Reply
    Bork, Konrad
    Hardt, Jochen
    AMERICAN JOURNAL OF MEDICINE, 2010, 123 (04): : E17 - E17
  • [34] Normal C1 Inhibitor Hereditary Angioedema Reply
    Patel, Nilesh N.
    Patel, Devesh N.
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (05): : E9 - E9
  • [35] Berotralstat Plasma kallikrein (KLKB1) inhibitor Treatment of hereditary angioedema attacks
    Gras, J.
    DRUGS OF THE FUTURE, 2021, 46 (01) : 21 - 28
  • [36] Subcutaneous DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema: results from the pivotal phase 3, double-blind, placebo-controlled EDEMA4 trial
    Levy, R.
    Lumry, W.
    McNeil, D.
    Li, H.
    Horn, P.
    Pullman, W.
    ALLERGY, 2009, 64 : 120 - 121
  • [37] Successful extubation with use of C1 esterase inhibitor concentrate in a patient with hereditary angioedema -: In reply
    Bork, K
    Siedlecki, K
    Bosch, S
    Schopf, RE
    Kreuz, W
    MAYO CLINIC PROCEEDINGS, 2000, 75 (08) : 870 - 870
  • [38] Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema
    Peters, Nicholas E.
    Mac Lochlainn, Dylan J.
    Dhalla, Fatima
    Howarth, Lucy
    Gupte, Girish L.
    Sharif, Khalid
    Jain, Rashmi
    Kelly, Dominic
    Patel, Smita Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (01): : 56 - 59
  • [39] Use of recombinant plasma kallikrein inhibitor in hereditary angioedema: A case report and review of the management of the disorder
    Turner, MD
    Ougbourli, A
    Heaney, K
    Selvaggi, T
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (12) : 1553 - 1556
  • [40] Plasma kallikrein activation in patients with hereditary angioedema due to C1 inhibitor deficiency
    Zanichelli, A.
    Maggioni, L.
    Cicardi, M.
    ALLERGY, 2009, 64 : 571 - 572
12345